Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...
from NDTV News - Topstories https://ift.tt/3lXILh9
Subscribe to:
Post Comments (Atom)
IRDAI approval paves way for Reliance Capital sale to IIHL
The Insurance Regulatory and Development Authority of India has given approval for a third Indian investor to hold 26% in Reliance Nippon Li...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Trading in stock markets this week will be majorly influenced by the upcoming quarterly earnings from IT majors TCS and Infosys, along with...
No comments:
Post a Comment